Is PACS Group, Inc. (PACS) overvalued? · P/E 23, rev $4.09B
PACS Group, Inc. (PACS) is a medical care facilities company listed on NYSE.
This page asks whether PACS Group, Inc. (PACS) looks expensive on cached numbers — not a short thesis.
Latest reported PACS revenue for 2024-12-31 was $4.09B. Net income was $55.3M. Revenue was up 337.1% from 2024-06-30 to 2024-12-31. PACS currently screens at market cap $5.58B and trailing P/E 22.7.
PACS currently screens at market cap $5.58B and trailing P/E 22.7. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next PACS 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the PACS stock page for the full model, not this heading.
Not investment advice.